Innovent Biologics, Inc.

IVBXF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Assets
Cash & Equivalents$9,540$7,508$8,165$10,052
Short-Term Investments$0$376$463$868
Receivables$1,722$1,567$1,369$1,006
Inventory$1,128$822$690$968
Other Curr. Assets$702$0$361$484
Total Curr. Assets$13,093$10,273$11,049$13,428
Property Plant & Equip (Net)$5,602$5,647$5,421$4,656
Goodwill$0$0$0$0
Intangibles$1,388$1,283$987$28
Long-Term Investments$3,132$3,901$2,301$794
Tax Assets$0$0$0$0
Other NC Assets$379$499$537$1,721
Total NC Assets$10,501$11,330$9,247$7,199
Other Assets$0$0$0$0
Total Assets$23,594$21,603$20,296$20,627
Liabilities
Payables$432$358$221$373
Short-Term Debt$1,115$414$1,012$1,220
Tax Payable$0$0$0$194
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,466$3,597$2,895$2,690
Total Curr. Liab.$5,012$4,369$4,128$4,477
LT Debt$2,265$2,417$2,337$2,400
Deferred Rev, NC$0$0$0$960
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,895$1,699$1,405$263
Total NC Liab.$4,160$4,116$3,742$3,623
Other Liabilities$0$0$0$0
Cap. Leases$8$14$143$99
Total Liabilities$9,172$8,485$7,869$8,100
Equity
Pref Stock$0$0$0$0
Common Stock$0$0$0$0
Retained Earnings-$15,072-$15,906-$16,160-$15,768
AOCI$1,305$1,301$1,042$971
Other Equity$28,189$27,723$27,544$27,324
Total Equity$14,422$13,118$12,426$12,528
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$23,594$21,603$20,296$20,627
Net Debt-$6,161-$4,677-$4,817-$6,432
Innovent Biologics, Inc. (IVBXF) Financial Statements & Key Stats | AlphaPilot